drugset
Drugs / Autologous Skin Fibroblasts
last change Sep 2019 re-read 3 minutes ago

Autologous Skin Fibroblasts

also known as autologous fibroblasts · volar fibroblast

Cell therapy

Investigated by
Johns Hopkins University · Maryland Stem Cell Research Fund · National Institutes of Health (NIH) · United States Department of Defense · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Trials 2

today NCT03947450 · Ph 2 NCT01964859 · Ph 2
20152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03947450 Sep 2019 → Apr 2028 expected — Johns Hopkins University Recruiting No outcome recorded
Phase 2 NCT01964859 Jan 2015 → Dec 2027 expected — Johns Hopkins University Recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as autologous skin fibroblasts ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964859 ↗
1

NCT03947450 ↗
Known as autologous fibroblasts “The site or whole stump will be injected with autologous fibroblasts” NCT03947450 ↗
Known as volar fibroblast “This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at...” NCT03947450 ↗
Modality Cell therapy “volar fibroblast (skin cells from the palm or sole) injections” NCT03947450 ↗